NASTAD Press Release

NASTAD Announces 2025-2026 Board of Directors

FOR IMMEDIATE RELEASE: May 30, 2025 

CONTACT: Kyle Taylor, Director, Communications, NASTAD 

Washington, DC – On Wednesday, May 21, NASTAD, a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S., announced its 2025-2026 Board of Directors. NASTAD is governed by a 24-member, elected Board charged with making policy and program decisions on behalf of the full membership. 

The 2025-2026 Board of Directors includes:   

Officers (Executive Committee) 

  • Sarah Braunstein (New York City), Chair 
  • Maria Jackson (Colorado), Chair-Elect 
  • Andy Dillehay (Nebraska), Vice-Chair 
  • Stella Martin (New Mexico), Secretary 
  • Tom Dunn (Michigan), Treasurer 
  • Clover Barnes (District of Columbia), Immediate Past-Chair (ex-officio, voting) 
  • Stephen Lee, NASTAD Executive Director (ex-officio, non-voting) 

Board Members 

  • Arlis Jenkins (Arizona) 
  • Tiffany Woods (California) 
  • Jorge Cestou (Chicago) 
  • Thaddeus Pham (Hawaii) 
  • Chelsea Frand (Houston) 
  • Andrea Perez (Illinois) 
  • Jeremy Turner (Indiana) 
  • Joyce Mbugua (Iowa) 
  • Debbie Guilbault (Kansas) 
  • Samuel Burgess (Louisiana) 
  • Barry Callis (Massachusetts) 
  • Dustin Hampton (Missouri) 
  • Anthony Hannah (North Carolina) 
  • Kathleen Brady (Philadelphia) 
  • Larisa Bruner (South Carolina) 
  • Phadre Johnson (Tennessee) 
  • Samuel Hebbe-Goings (Texas) 
  • Syd Robinson (Wisconsin) 

“I am elated to welcome the 2025-2026 NASTAD Board of Directors,” said Stephen Lee, NASTAD Executive Director. “I am eager to work alongside these Board members to help health departments navigate and overcome obstacles as we continue our work of ending the HIV/AIDS and hepatitis epidemics.” 

### 

About NASTAD Founded in 1992, NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening governmental public health through advocacy, capacity building, and social justice.